Found 146 matching trials
Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS PHASE2 This study compares the safety and effectiveness of giving rivogenlecleucel...
Show More Location
TriStar Bone Marrow Transplant, LLC
Learn More & Join Trial
Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis PHASE1 This pilot clinical trial studies the side effects and best dose of ruxolit...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Randomized Clinical Study Assessing Haplo vs. URD in AML NA This study compares haplo-identical family donor stem cell transplantation ...
Show More Location
Medical University of Vienna
Learn More & Join Trial
Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation PHASE1 In this trial, the investigators will begin to explore the possibility that...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Phase I Clinical Trial to Assess Safety of UV Phototherapy for the Prevention of GVHD Post Allogeneic SCT PHASE1 The primary goal of thos study is to assess safety of Ultraviolet (UV) Phot...
Show More Location
Hadassah Medical Organization
Learn More & Join Trial
Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years PHASE2 Outcomes for adult patients with Severe Aplastic Anemia (SAA) aged more tha...
Show More Location
Saint Louis hospital
Learn More & Join Trial
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant PHASE2 The researchers are doing this study to compare 2 different GVHD prevention...
Show More Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial
A Randomized Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation NA This is a single-center, prospective, randomized, open-label clinical trial...
Show More Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation PHASE3 The purpose of this pivotal study is to determine if intravenous Rezafungin...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia PHASE2 Cord blood (CB) transplants are an option for patients lacking an HLA ident...
Show More Location
University of Colorado School of Medicine. Anschutz Medical Campus
Learn More & Join Trial